BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18232624)

  • 1. NT-proBNP levels and resting hemodynamic parameters assessed by bioimpedance in patients with chronic heart failure.
    Feliciano J; Soares R; Silva S; Fiarresga A; Fernandes RM; Miranda F; Ferreira RC
    Rev Port Cardiol; 2007 Oct; 26(10):1021-8. PubMed ID: 18232624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between NT-proBNP values and changes in functional capacity in patients with chronic heart failure.
    Fernandes R; Feliciano J; Soares RM; Mamede A; Ramos R; Miranda F; Silva S; Timóteo AT; Abreu A; Ferreira R
    Rev Port Cardiol; 2007 Dec; 26(12):1329-44. PubMed ID: 18338663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP values and Weber functional class in patients with chronic heart failure.
    Fernandes R; Feliciano J; Soares RM; Mamede A; Ramos R; Silva S; Serra J; Oliveira JA; Abreu J; Abreu A; Ferreira R
    Rev Port Cardiol; 2007 Dec; 26(12):1311-24. PubMed ID: 18338662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM; Beckers P; Vaes J; Martin M; Van Hoof V; De Maeyer C; Possemiers N; Wuyts FL; Vrints CJ
    Eur Heart J; 2004 Oct; 25(20):1797-805. PubMed ID: 15474694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels.
    Arad M; Adler Y; Koren-Morag N; Natanzon S; Sela BA; Ben Dov I; Shechter M; Schwammenthal E; Freimark D
    Int J Cardiol; 2008 May; 126(1):114-9. PubMed ID: 17651845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP.
    Knebel F; Schimke I; Diaz Ramirez I; Schattke S; Eddicks S; Borges AC; Baumann G
    Int J Cardiol; 2009 May; 134(2):260-3. PubMed ID: 18384896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
    Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure].
    Zhang YH; Lü R; Zhao XY; Kang LM; Yang YJ; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):126-9. PubMed ID: 19719987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S; Adamopoulos S; Parissis JT; Rassias J; Kostakis G; Iliodromitis E; Degiannis D; Kremastinos DT
    Int J Cardiol; 2005 Mar; 99(3):409-13. PubMed ID: 15771921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
    Sargento L; Brito D; Matias JS; Madeira H
    Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
    Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
    Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The association study of serum total bilirubin, plasma N-terminal proBNP and invasive hemodynamic parameters in patients with heart failure].
    Zhang YH; Zhang J; Wang D; Lü R; Wei BQ; Kang LM
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):313-5. PubMed ID: 20627038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity does not influence the correlation between exercise capacity and serum NT-proBNP levels in chronic heart failure.
    Ferreira AM; Mendes M; Ventosa A; Aguiar CT; Ferreira J; Figueira JM; Silva JA
    Int J Cardiol; 2008 Oct; 130(1):103-5. PubMed ID: 17692409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.